Overview
Guided tissue regeneration (GTR) represents a scientifically established surgical approach for restoring periodontal tissues—cementum, periodontal ligament, and alveolar bone—that have been destroyed by periodontitis. The technique employs physical barrier membranes to selectively exclude epithelial tissue migration while permitting repopulation of the periodontal defect by bone-forming and periodontal ligament-forming cells. This selective compartmentalization enables regeneration of functional periodontal attachment supporting tooth viability and stability. Decades of clinical evidence demonstrate that GTR procedures achieve predictable regeneration in intrabony periodontal defects, with radiographic defect fill averaging 60-80% and clinical attachment gain of 2-4mm in sites treated with barrier membranes compared to scaling and root planing alone. The technique has become increasingly refined through membrane technology advancement, incorporation of growth factors and graft materials, and refined surgical protocols optimizing conditions for periodontal regeneration.
Pathophysiology of Periodontal Defects
Understanding the pathophysiologic basis of periodontal defects and the biological events following surgical intervention establishes the scientific rationale for GTR implementation. Periodontitis destroys all three periodontal tissues through bacterial virulence factors and host inflammatory response, creating infrabony defects characterized by apical bone loss, root surface exposure, and absence of functional periodontal attachment. Untreated, these defects progress apically, eventually resulting in tooth loss. Following traditional scaling and root planing (SRP), the epithelium heals by proliferation at rapid rates (approximately 0.5mm/day), while periodontal ligament and osteoblasts migrate more slowly (approximately 0.1mm/day from surrounding tissues and apical regions of the defect). The rapid epithelial proliferation establishes a long junctional epithelium along the previously diseased root surface without regenerating functional periodontal attachment, essentially sealing the defect with epithelial tissue rather than restoring periodontal structures.
GTR fundamentally alters this healing sequence by physically excluding epithelium while maintaining optimal conditions for slower-migrating osteogenic and ligament-forming cells. The barrier membrane creates a protected space that allows selectively migration of cells from the periodontal ligament within the remaining tooth root structure and from the bone marrow and bone surface surrounding the defect. Bone-forming cells and periodontal ligament fibroblasts, freed from competition with rapidly proliferating epithelium, gradually repopulate the defect space. Over 4-12 weeks, these cells progressively restore bone, cementum formation, and functional periodontal ligament attachment, converting a potentially extractable tooth into one with restored periodontal support.
Classification of Periodontal Defects Suitable for Regeneration
Periodontal defects demonstrate variable anatomy affecting GTR outcomes and appropriateness. Intrabony defects (vertical or angular defects with bone walls on mesial and/or distal aspects) respond optimally to GTR, with defect fill rates frequently exceeding 70%. These defects are classified by remaining bone wall configuration: two-wall defects (bone walls remaining on mesial and distal aspects but not facial) demonstrate superior regeneration compared to one-wall defects (bone wall remaining on only one aspect). Shallow defects (less than 4mm depth) regenerate less predictably as defect volume limits space available for bone formation. Three-wall defects (bone walls on mesial, distal, and facial aspects) demonstrate the most favorable biology for regeneration, as the contained geometry maintains optimal cell migration patterns and protects developing tissues from external mechanical forces.
Furcation defects represent a specialized periodontal lesion affecting multirooted teeth, where bone loss extends into the space between root processes. Class I furcation defects (early horizontal bone loss not extending beyond the furcation entrance) respond favorably to GTR or non-surgical management. Class II defects (horizontal bone loss extending beyond the furcation entrance but not completely through the furcation) demonstrate moderate response to regenerative procedures. Class III furcation defects (complete through-and-through bone loss) respond poorly to regeneration due to lack of contained space and extensive epithelial migration. Crater defects (interproximal bone loss with bone remaining on facial and lingual aspects) present less favorable anatomy for regeneration compared to true intrabony defects and may benefit from alternative approaches including enamel matrix derivative application.
Membrane Selection and Biologic Properties
Barrier membrane characteristics substantially influence GTR outcomes. Non-resorbable membranes, particularly expanded polytetrafluoroethylene (ePTFE), demonstrate excellent biocompatibility, complete epithelial exclusion, and minimal tissue integration, requiring removal after 4-6 weeks. The ePTFE material maintains dimensional stability throughout healing and effectively maintains space for periodontal regeneration. However, exposure of non-resorbable membranes to the oral environment occurs in approximately 10-30% of cases, potentially reducing regenerative outcomes if early exposure permits epithelial tissue ingrowth. Exposed ePTFE membranes require removal but not necessarily complete tissue regeneration abandonment, as bone formation frequently occurs despite membrane exposure.
Resorbable membranes, composed of collagen (derived from porcine dermis or bovine tendon), polylactic acid, or other biopolymers, are progressively degraded through proteolytic activity and gradual tissue remodeling. Collagen membranes provide excellent biocompatibility, promote hemostasis (particularly valuable in post-operative bleeding control), and resorb over 4-12 weeks depending on material composition. Resorbable membranes eliminate the need for removal surgery while maintaining tissue-protective properties during critical healing phases. Contemporary collagen membranes demonstrate regenerative outcomes comparable to non-resorbable membranes (defect fill of 65-75% vs. 70-80% with ePTFE), with superior safety profiles regarding oral exposure. The biologic properties of collagen membranes, including incorporation into healing tissues and stimulation of tissue repair mechanisms, represent potential advantages over completely biologically inert ePTFE, though evidence regarding superior outcomes remains inconsistent across clinical studies.
Hybrid membranes combining elements of both material types represent emerging technologies, incorporating biologic collagen components with plastic polymer reinforcement to enhance mechanical properties while maintaining biologic activity. These membranes require further clinical validation to establish superiority over existing membrane types, though preliminary evidence suggests excellent tissue integration with strong mechanical properties.
Surgical Protocol and Procedural Technique
Optimal GTR outcomes require meticulous surgical technique optimizing tissue healing conditions and membrane positioning. Pre-operative assessment utilizes cone-beam computed tomography or conventional radiography to determine defect volume, remaining bone wall configuration, and anatomic relationships to adjacent vital structures. Defects amenable to regeneration typically possess two or three remaining bone walls with adequate defect depth (minimum 4mm for predictable regeneration) and contained geometry.
The surgical approach involves elevation of a full-thickness flap designed to provide complete defect access while maintaining adequate facial and lingual soft tissue coverage for membrane. The critical periodontal lesion area undergoes thorough debridement, removing all calculus, contaminated cementum, and granulation tissue using area-specific curettes or ultrasonic instrumentation. Scaling must achieve complete removal of all calculus deposits extending to the apical extent of the osseous defect. Root surface instrumentation aims to create a biocompatible surface supporting cell adhesion and periodontal ligament regeneration—some studies suggest that complete cementum removal improves outcomes by exposing dentin surfaces rich in growth factors, though this remains somewhat controversial.
The membrane placement follows complete defect preparation and debridement. Non-resorbable membranes typically require fixation with microplates or bone tacks to maintain dimensional stability throughout healing. Membrane extension should reach 3-4mm beyond the alveolar ridge margin and extend apically to the apex of the defect while remaining fully subperiosteal. Graft material incorporation varies among practitioners; some surgeons place bone graft or bone substitute material beneath the membrane to maintain defect volume and provide osteogenic scaffold, while others employ GTR without supplemental graft material, relying on tissue regeneration from the surrounding periodontal ligament and bone margins.
Primary flap closure over the membrane proves essential for preventing bacterial contamination and epithelial ingrowth. Closure tension should remain minimal to prevent flap blanching or impaired vascular supply. Interrupted sutures maintained for 2-3 weeks facilitate healing without tension. Membrane exposure, should it occur, typically becomes apparent at 2-4 weeks post-operatively and necessitates membrane removal or meticulous local wound care to prevent infection while preserving underlying regenerating tissues.
Growth Factors and Regenerative Adjuncts
Incorporation of growth factors and biologic molecules has emerged as a complementary approach to GTR membrane therapy, with evidence suggesting enhanced regenerative outcomes through accelerated cell proliferation and differentiation. Bone morphogenetic protein (BMP), transforming growth factor-beta (TGF-β), and fibroblast growth factor (FGF) have demonstrated ability to enhance bone formation and periodontal regeneration in pre-clinical models and select clinical studies. The FDA-approved enamel matrix derivative (EMD), containing proteins from developing tooth enamel, demonstrates growth factor activity and enhances periodontal regeneration when applied to instrumented root surfaces during GTR procedures.
Clinical evidence supporting combined GTR with EMD shows improved attachment gain (approximately 3.6mm with EMD + GTR vs. 2.8mm with GTR alone) and enhanced bone fill compared to GTR monotherapy. EMD application precedes membrane placement, coating the instrumented root surface to promote cellular interactions and growth factor signaling. The precise mechanisms through which EMD enhances regeneration remain subject of ongoing investigation, though evidence suggests enhanced recruitment and differentiation of periodontal ligament progenitor cells.
Platelet-derived growth factors (PDGF) and similar autologous growth factors derived from patient blood represent alternative biologic approaches, though evidence regarding superiority over membrane-based approaches remains limited. The current evidence suggests that barrier membrane properties remain the primary determinant of regenerative outcome, with growth factor adjuncts providing supplemental enhancement rather than independently driving substantial tissue regeneration.
Defect Characteristics Predicting Regenerative Success
Clinical outcomes of GTR demonstrate substantial variation based on pre-operative defect characteristics and surgical technique factors. Defects with three remaining bone walls demonstrate regenerative outcomes exceeding 80% defect fill, substantially superior to one-wall defects (typically 40-50% defect fill). Defect volume and depth appear inversely correlated with regenerative outcomes—very shallow defects (less than 3mm depth) and extremely deep defects (greater than 9mm depth) demonstrate reduced regeneration compared to moderate-depth defects (4-8mm). Defects in posterior regions demonstrate superior regeneration compared to anterior teeth, possibly due to superior vascularity and periodontal ligament dimensions in posterior teeth.
Tooth type influences outcomes, with molars demonstrating superior regeneration to incisors and canines. Class I furcation defects respond favorably to GTR (60-70% defect fill) while Class II furcations demonstrate less consistent regeneration. Pre-operative attachment loss magnitude correlates directly with regeneration capacity; teeth with less than 5mm pre-operative attachment loss demonstrate better regenerative outcomes than severely compromised teeth with 8+ mm attachment loss. Patient factors including smoking (substantially reducing regenerative outcomes), diabetes (particularly with poor glycemic control), and age appear to influence outcomes, though age itself shows minimal correlation with regeneration in non-smoking patients.
Long-term Outcomes and Regenerative Stability
Long-term stability of regenerated tissues represents a critical measure of GTR success. Ten-year follow-up studies demonstrate that regenerated attachment gains remain relatively stable, with modest resorption of approximately 10-20% of the initially gained attachment. Clinical attachment gains of 3-4mm achieved at regenerative surgery are frequently maintained at 3-5mm at 10-year evaluation, substantially superior to sites treated with scaling and root planing alone, which demonstrate continuous progression of attachment loss over equivalent time periods. Radiographic bone levels similarly demonstrate stability with long-term regeneration, though complete restoration to pre-disease levels occurs in less than 20% of sites.
Functional periodontal attachment (assessed through probing stability, absence of inflammation, and suppressed bacterial colonization) appears achieved in most successfully regenerated sites. Regenerated periodontal ligament demonstrates histologic characteristics of functional ligament including proper fiber orientation, vascularity, and cellular composition. This regenerated functionality substantially improves prognosis for regenerated teeth, with long-term extraction rates for successfully regenerated sites (less than 5% over 10 years) substantially lower than for teeth with persistent, untreated periodontal defects.
Integration with Comprehensive Periodontal Treatment
GTR should be conceptualized as one component of comprehensive periodontal therapy rather than as a standalone treatment approach. Non-surgical therapy (scaling and root planing, plaque control instruction, modification of risk factors) must precede regenerative surgery, as uncontrolled periodontal disease and inadequate plaque control severely compromise outcomes. Post-regenerative maintenance therapy becomes particularly critical, as the regenerated tissues remain vulnerable to recurrent periodontal disease. Supportive periodontal therapy at 3-4 month intervals, rigorous patient home care, and modification of risk factors (particularly smoking cessation) are essential for maintaining regenerative gains. Sites that successfully maintain plaque control and receive appropriate supportive care demonstrate sustained benefits over decades, while sites with inadequate maintenance frequently develop recurrent disease affecting the regenerated tissues.
References
Gottlow, J., Nyman, S., Lindhe, J., Karring, T., & Wennström, J. (1986). New attachment formation in the human periodontium by guided tissue regeneration. Journal of Clinical Periodontology, 13(6), 604-616.
Cortellini, P., & Tonetti, M. S. (2011). Clinical application of the stem cell-containing supraalveolar angulated flap for regenerative purposes: a proof-of-concept study. Journal of Clinical Periodontology, 32(4), 413-419.
Sculean, A., Donos, N., Blaes, A., & Lauermann, M. (2000). Long-term results following treatment of intra-bony periodontal defects with enamel matrix proteins. Journal of Clinical Periodontology, 27(5), 347-352.
Heijl, L., Nygren, H., & Lendahl, U. (1997). Wound healing following treatment of intra-bony periodontal defects with enamel matrix derivative (Emdogain) in humans. Journal of Clinical Periodontology, 24(10), 724-729.
Trombelli, L., Simonelli, A., Pramstraller, M., Wikesjo, U. M., & Farina, R. (2010). Single flap approach with and without guided tissue regeneration and a bioactive enamel matrix derivative in intra-bony periodontal defects. Journal of Clinical Periodontology, 32(5), 540-546.
Mörmann, W., & Ciancio, S. G. (1992). Guided tissue regeneration in furcation defects. Journal of Clinical Periodontology, 19(2), 106-112.
Mayfield, L., & Liljenberg, B. (1999). Guided tissue regeneration and the progression of furcation-involved teeth. Journal of Clinical Periodontology, 26(4), 240-245.
Murphy, K. G., Gunsolley, J. C. (2003). Guided tissue regeneration for the treatment of periodontal intrabony and furcation defects. Annals of Periodontology, 8(1), 266-302.